IP3R-I Antibodies

Santa Cruz Biotechnology delivers a wide array of IP3R-I monoclonal antibodies for the specific detection and analysis of inositol 1,4,5-trisphosphate receptor type I. IP3R-I monoclonal antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The inositol 1,4,5-trisphosphate receptor type I plays a central role in calcium signaling pathways, mediating the release of calcium ions from the endoplasmic reticulum in response to cellular stimuli. IP3R-I is essential for various physiological processes, including muscle contraction, neurotransmitter release, and cell proliferation. Understanding the function and regulation of IP3R-I contributes significantly to research in cellular functions and disease states. Researchers worldwide rely on IP3R-I monoclonal antibodies to advance their studies in calcium signaling mechanisms. IP3R-I monoclonal antibodies enable precise detection and characterization of signaling pathways across diverse experimental conditions. The exceptional specificity of IP3R-I monoclonal antibodies from Santa Cruz Biotechnology continues to support breakthrough discoveries in calcium signaling research and cellular biology.